DARETherapeutics - Developing a Next Generation Treatment for Wet AMD and DME
A novel target and antibody for stand-alone or combination therapeutics against conditions involving neovascularization
- Intellectual property rights are held by University of Southern Denmark (WO2014114298 and EP17199552.5).
- Patent application submitted
- Seeking investment
- Development partner
- Commercial partner